The National Public Health Institute of Liberia (NPHIL), under the strategic leadership of Director General Dr. Dougbeh Chris Nyan, has issued a sobering update regarding the resurgence of Mpox across the nation. As of May 22, 2025, NPHIL has confirmed the presence of 25 active cases, a development that has triggered heightened surveillance protocols and emergency mobilization efforts across all 15 of Liberia’s counties. This latest data set, covering the period from January 1, 2024, to May 22, 2025, reveals a total of 676 suspected cases.
Following rigorous laboratory analysis of 596 samples, the official confirmed count has reached 102 cases. While the absence of reported fatalities thus far serves as a significant relief to the public health sector, the widespread geographic distribution of the virus—impacting every county—presents a daunting logistical challenge for an already stretched health infrastructure. The declaration of these figures at a recent Ministry of Information, Cultural Affairs and Tourism (MICAT) press briefing underscores the gravity with which the Liberian government views this silent, creeping epidemic. Dr.
Nyan, a renowned scientist and public health advocate, has been vocal about the necessity for a shift from passive observation to active, community-driven prevention. His message is clear: the virus is present in our communities, and the threshold for complacency has long since been crossed. Mpox, formerly known as monkeypox, is a zoonotic orthopoxvirus that causes symptoms resembling smallpox but is clinically less severe. However, in the context of Liberia’s post-conflict and post-epidemic recovery trajectory, even a manageable disease like Mpox carries significant economic and social risks.
The burden of this outbreak is not merely the clinical management of patients; it is the disruption of trade, the anxiety induced in urban marketplaces, and the potential strain on health facilities that are already battling endemic diseases like malaria, tuberculosis, and HIV. The historical context of public health in Liberia is inextricably linked to the scars left by the 2014–2015 Ebola Virus Disease (EVD) crisis. That period remains the defining moment for modern Liberian health policy. It decimated the healthcare workforce, shattered public trust in clinical facilities, and laid bare the severe inadequacies in the country’s surveillance and diagnostic capabilities.
Yet, out of that tragedy emerged the infrastructure that is now being tested by Mpox. The establishment of NPHIL itself was a direct response to the need for a centralized, scientific body capable of managing infectious disease threats without the crippling delays seen during the early days of Ebola. The lessons learned from Ebola—the absolute necessity of community engagement, the role of traditional leaders as health messengers, and the critical importance of localized surveillance—were further refined during the global COVID-19 pandemic. During the pandemic, Liberia won international acclaim for its tactical responses, including the rapid deployment of mobile testing units, the utilization of existing contact tracing networks, and a pragmatic approach to border screenings at major entry points like Roberts International Airport and land crossings in Nimba and Grand Gedeh.
These systems, however, are now experiencing ‘institutional fatigue.’ Maintaining a high level of vigilance without the intense international funding spikes that typically accompany major global outbreaks is the primary hurdle for Dr. Nyan and his team. The current strategy for combating Mpox relies heavily on the 'three pillars' of the Liberian response: communication, prevention, and surveillance.
Dr. Nyan has repeatedly emphasized that the media must serve as the first line of defense. By disseminating accurate information, the press acts as a buffer against the 'infodemic'—the spread of rumors and medical misinformation that frequently undermined control efforts in previous years. Whether it is regarding the mode of transmission or the availability of supportive treatment, misinformation can cause panic, leading individuals to avoid testing centers until their symptoms have progressed significantly.
Preventing transmission requires a high degree of social cooperation. The NPHIL guidelines are intentionally simple yet difficult to sustain: frequent handwashing, strict avoidance of direct skin-to-skin contact with suspected cases, and the immediate isolation of those presenting with rashes or fever. These measures are often easier to state than to implement in Liberia’s densely populated urban centers or remote rural villages, where communal living remains a fundamental cultural reality. Economic implications for Liberia remain a concern if the outbreak persists or accelerates.
Small-scale commerce in markets like Duala or Red-Light is highly tactile and social. Any suggestion of a lockdown or movement restriction, even if unfounded, could severely disrupt the livelihoods of thousands of Liberians living on daily wages. Therefore, the government is prioritizing a localized, non-restrictive approach, focusing on identifying clusters of infection rather than blanket measures that could trigger economic fallout. Furthermore, the regional context cannot be ignored.
Liberia does not exist in a public health vacuum. The surge of Mpox in neighboring Sierra Leone and other parts of West Africa means that cross-border surveillance is not merely a bureaucratic exercise but an essential component of national security. The West African sub-region is highly mobile, with porous borders and robust informal trade networks. A failure to synchronize responses between Monrovia and Freetown could lead to the constant reintroduction of the virus, turning local outbreaks into a permanent regional fixture.
Dr. Nyan’s recent engagements with international partners, including the United Nations Development Programme (UNDP), signify an understanding that the national response requires global technical and financial support. There is a clear need for increased funding to decentralize diagnostic capabilities; currently, samples often have to be transported to central labs, creating time lags that allow for further community transmission. Strengthening regional labs and training health workers at the district level to recognize, report, and isolate Mpox cases are critical priorities.
Moreover, the long-term solution to outbreaks of this nature lies in strengthening the 'One Health' approach—a collaborative effort to understand the links between human health, animal health, and environmental changes. As deforestation continues in regions across Liberia, the encroachment of human activity into animal habitats increases the likelihood of zoonotic spillover events. Addressing Mpox is not just about the current 25 active cases; it is about building a system that is resilient enough to detect, contain, and treat these illnesses before they spiral. The road ahead for NPHIL is steep.
Public fatigue toward government health directives is a reality that cannot be ignored. To succeed, the government must move beyond simply announcing statistics and move toward sustained, empathetic community dialogue. Transparency, as NPHIL has repeatedly promised, will be the currency that buys the public’s continued compliance. If the people believe that the government is providing honest, timely data, they are far more likely to adhere to the recommended safety protocols.
As the country monitors the 25 active cases, the spotlight remains on the effectiveness of the established surveillance net. Every negative result in the laboratory is a victory, and every confirmed case is a reminder that the war against infectious disease is a permanent state of affairs in the 21st century. Liberia’s success in managing this outbreak will be a test of the systems built in the wake of its darkest days and an indicator of its maturity in managing public health crises in an increasingly interconnected world. For now, the call to action is clear: vigilence, adherence to protocol, and a unified national response are the only path forward.
